Hardy Reed LLC Increases Position in UnitedHealth Group Incorporated $UNH

Key Points

• Hardy Reed LLC increased its stake in UnitedHealth Group by 41.7%, now holding 5,933 shares worth approximately $1.85 million.
• Several institutional investors have also raised their positions in UnitedHealth Group, with Brighton Jones LLC increasing its stake by 176.2% during the last quarters.
• UnitedHealth Group's stock is currently averaging a price target of $358.95, with 16 analysts rated as "Buy" and four as "Sell".

Hardy Reed LLC boosted its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 41.7% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 5,933 shares of the healthcare conglomerate's stock after acquiring an additional 1,745 shares during the period. Hardy Reed LLC's holdings in UnitedHealth Group were worth $1,851,000 as of its most recent SEC filing.

A number of other institutional investors have also modified their holdings of the stock. Brighton Jones LLC increased its position in UnitedHealth Group by 176.2% during the 4th quarter. Brighton Jones LLC now owns 44,249 shares of the healthcare conglomerate's stock worth $22,384,000 after purchasing an additional 28,231 shares during the period. Revolve Wealth Partners LLC raised its position in UnitedHealth Group by 137.1% in the fourth quarter. Revolve Wealth Partners LLC now owns 4,019 shares of the healthcare conglomerate's stock worth $2,033,000 after acquiring an additional 2,324 shares in the last quarter. Wedge Capital Management L L P NC boosted its position in shares of UnitedHealth Group by 10.8% during the 1st quarter. Wedge Capital Management L L P NC now owns 20,461 shares of the healthcare conglomerate's stock worth $10,716,000 after purchasing an additional 1,997 shares in the last quarter. First Citizens Bank & Trust Co. increased its holdings in shares of UnitedHealth Group by 5.0% in the 1st quarter. First Citizens Bank & Trust Co. now owns 40,443 shares of the healthcare conglomerate's stock valued at $21,182,000 after purchasing an additional 1,923 shares in the last quarter. Finally, Wesbanco Bank Inc. boosted its holdings in UnitedHealth Group by 0.7% during the first quarter. Wesbanco Bank Inc. now owns 52,206 shares of the healthcare conglomerate's stock worth $27,343,000 after buying an additional 338 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently issued reports on UNH shares. Truist Financial lifted their price target on shares of UnitedHealth Group from $310.00 to $365.00 and gave the company a "buy" rating in a research report on Tuesday, September 9th. Oppenheimer decreased their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Robert W. Baird reaffirmed an "underperform" rating and set a $198.00 price target (down previously from $312.00) on shares of UnitedHealth Group in a research note on Thursday, July 31st. Sanford C. Bernstein increased their price objective on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research note on Friday, September 5th. Finally, Piper Sandler reduced their price target on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating on the stock in a report on Wednesday, July 30th. Sixteen investment analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Hold" and a consensus target price of $358.95.

UnitedHealth Group Price Performance

UnitedHealth Group stock opened at $358.95 on Tuesday. The firm's 50-day moving average is $309.38 and its two-hundred day moving average is $352.34. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The stock has a market capitalization of $325.09 billion, a P/E ratio of 15.55, a P/E/G ratio of 2.34 and a beta of 0.47. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last announced its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter last year, the business posted $6.80 EPS. The firm's revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Equities analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is presently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.